ISI Impact Factor (2004): 1.096


   
 

Editor-in-Chief
Prof. Yi-Fei WANG,

 
     

   

Cytokines in the BALB/c mouse testis in various conditions

E. Veräjänkorva1, M. Martikainen1,  P. Pöllänen1,2

Department of Anatomy1 and Department of Obstetrics and Gynecology2, University of Turku, FIN-20520 Turku, Finland

 Asian J Androl  2001 Mar; 3: 9-19


Keywords: testosterone; vasectomy; estrogens; cryptorchidism; abdominal testis;  varicocele; cyokines; IL-10; macrophages; clonal anergy
Abstract

Aim: To investigate whether testosterone, estrogens, vasectomy, experimental cryptorchidism, varicocele or aging would induce changes in the cytokine environment of the mouse testis. Methods: In adult male BALB/c mice, testosterone implants, estradiol benzoate, vasectomy, unilateral cryptorchidism, unilateral varicocele were administered/performed. The mice were followed up for different periods of time and were then sacrificed with testes incised for examination. The control mice received the vehicle or sham-operation. Results: IL-10 was present in Leydig cells of nearly every testis and IL-10+ macrophages in 39% of testes. IL-6 was found in the testes of intact adult mice, mice treated with testosterone for 70 days, cryptorchid testes and sham-operated testes. Conclusion:  Results suggest that IL-10 might be involved in the generation of the immunologically privileged microenvironment in the testis.

1 Introduction

Testis is an immunologically privileged site where nearly every pathological condition of the male reproductive tract is associated with an increased prevalence of sperm antibodies[1]. The cytokines have two major roles in the testis: 1) to mediate pathophysiological outcomes of immune-endocrine interactions during inflammatory disease, 2) to work as growth and differentiation factors that help to orchestrate cellular interactions during normal physiological functions[2]. It is known that the cells responsible for the maintenance of the blood-testis barrier in the testis, the Sertoli cells, produce an IL-1α-like factor[3,4] and IL-6[5-7], as well as TGFβ[8-10] and Fas Ligand[11]. In addition, it has been reported that IL-11[12] is expressed in differentiating male germ cells. IFN-α and -γ[13] and TNF-α[14] are produced by testicular cells. However, a comprehensive study on the cytokine environment of the testis in physiological as well as pathological conditions has not yet been made.

The cells mainly responsible for protection of germ cells from autoimmune reactions, the Sertoli cells and the principal cells of the epididymis, are dependent on androgens[15,16], the concentration of which is decreased in both the testis and the epididymis during male hormonal contraception[17]. A decrease in androgen level may result in the breakdown of blood-testis and blood-epididymis barrier, the release of sperm autoantigens and the development of autoimmune destruction of the male reproductive tract. Indeed, it has been reported that the blood-testis barrier starts to break down in conditions of subnormal testosterone production in the seasonal breeder mink[16] with the formation of sperm antibodies[18]. In such a process, cytokines should have a distinctive role. This is also true in case of disrupting spermatogenesis in cryptorchidism[19] and vasectomy[20,21]. In all these conditions, the microenvironment of the testis might have been changed.

In the present study, the testicular cytokine balance was studied in various conditions to see, if any changes in the cytokine balance could predispose to initiate anti-germ cell immune response and ultimately to the formation of sperm antibodies.
2 Materials and methods

2.1 Animals

BALB/c male mice 2 (prepubertal), 4 (pubertal), 11 and 25 weeks of age were used as donors of normal testicular tissue. Each group consisted of at least three mice. The animals had free access to food and water and they were maintained in a normal dark/light cycle. Permissions for the experiments and to use organs from the animals after sacrifice with CO2 (Permission № 659/96) were granted by the local animal authorities.

2.2 Antibodies

Monoclonal antibodies against mouse cytokines were used as primary antibodies. The antibodies were as follows: rat-anti-mouse IL-2 (IgG2a; Pharmingen, clone S4B6), rat-anti-mouse IL-4 (IgG1; Pharmingen, clone 11B11), rat-anti-mouse IL-6 (IgG1; Pharmingen, clone MP5-20F3), rat-anti-mouse IL-10 (IgG2b; Pharmingen, clone JES5-16E3), rat-anti-mouse IL-12 (IgG1; Pharmingen, clone C15.6, reactive to the p40 subunit), rat-anti-mouse TNF-α (IgG1; Pharmingen, clone MP6-XT3), rat-anti-mouse IFN-γ (IgG1; Pharmingen, clone R4-6A2) and rat anti-mouse CD106 (VCAM-, c lone CRL1909, IgG2a). The antibodies bind in the used conditions specifically to their epitopes in the following mouse tissues: IL-2: experimental testicular teratoma of the Sv 129 strain[7]; IL-4: eosinophils (C57BL/6Jbom x transgenic HIRKO strain); IL-6: pancreas of the NOD/SCID strain after adoptive transfer of NOD splenocytes[22]; IL-10: pancreas of the NOD/SCID strain after adoptive transfer of NOD splenocytes[22]; IL-12: keratinocytes (C57BL/6Jbom x transgenic HIRKO strain); IFN-γ NOD/SCID pancreas after adoptive transfer of NOD splenocytes[22]; TNF-α NOD/SCID pancreas after adoptive transfer of NOD[22];CD106: scid mouse pancreas after adoptive transfer of NOD[23].

2.3 Administration of testosterone

To simulate the male hormonal contraception, a subcutaneous silastic (medical grade tubing, ID 3.35 mm, OD 4.65 mm, Aromando Medizintechnik, Düsseldorf, Germany; closed with Medical adhesive silicone type A, Dow Corning Medical Products, Midland, Michigan, USA) testosterone implant (one cm in length) or an empty (control) implant was introduced through a small incision under the back skin of 12 normal, over 11-weeks old male mice under pentobarbital anaesthesia (60 mg/kg, Mebunat, Orion, Finland). The wound was closed with 5-0 Dermalon (American Cyanamid company, Wayne, NJ, USA) sutures. The mice were followed for 17, 35, 52 and 70 days, after which they were sacrificed with CO2. The testes were collected and frozen in liquid nitrogen for later use.

2.4 Administration of estrogens

A volume of 150 μL of an estrogen preparation (0.375 mg Estradiol. benz., 1.5 mg Estradiol. phenylpropion; Dimenformon ProlongatumR, N. V. Organon, Oss, Holland) was injected ip of over 11 weeks old male mice. The mice were followed for seven days, after which they were sacrificed with CO2. The testes were collected and frozen in liquid nitrogen.

2.5 Vasectomy

Mice (n=12) were vasectomized through a mid-abdominal incision under pentobarbital anaesthesia. The vasa were exposed and ligated using 5-0 Dermalon sutures at two sites 5 mm from each other and cut between the sutures with scissors. Sham-operated animals were handled similarly except that the vasa were left intact. The abdominal wound was closed using 5-0 Dermalon sutures. The mice were followed for 17, 35, 52 and 70 days, after which they were sacrificed with CO2. The testes were collected and frozen in liquid nitrogen.

2.6 Cryptorchidism

Mice (n=3) were made unilaterally cryptorchid through mid-abdominal incision under pentobarbital (MebunatR, Orion, Turku, Finland) anaesthesia. The left testis was drawn from the scrotum to the abdominal cavity and sutured to the parietal peritoneum with 5-0 Dermalon sutures. Sham*-operated animals were handled similarly except that both testes were left intact. The mice were followed for seven days, after which they were sacrificed with CO2. The testes were collected and frozen in liquid nitrogen for later use.

2.7 Varicocele

The left spermatic vein of three mice was ligated via a mid-abdominal incision under pentobarbital anaesthesia. Sham-operated mice were handled similarly except that the spermatic vein was left intact. The abdominal wound was closed in one layer using 5-0 Dermalon sutures. The mice were followed for 14 days, after which they were sacrificed with CO2. The testes were collected and frozen in liquid nitrogen for later use.

2.8 Indirect immunofluorescence (IF)

Frozen sections 2-5 μm in thickness were cut in a cryostat. They were air-dried briefly at room temperature and then fixed in cold acetone (-20) for 1-2 minutes. The sections were stored at -20and just before use, they were soaked in PBS. The non-specific binding sites were blocked by incubating the section in 5% normal rabbit serum in PBS (pH 7.4) for 15-20 minutes. After washing in PBS, blocking of non-specific binding sites was continued with 5% normal rat serum in PBS for 15-20 minutes. The sections were washed in PBS. Then they were incubated with the primary antibodies (diluted into the concentration of 2.0 μg/mL in 1% BSA in PBS; Sigma, St. Louis, MO) for 60 minutes. The sections were washed in PBS and incubated for 60 minutes with the secondary antibody (FITC-conjugated rabbit-anti-rat Ig, Dako, cat no. F 0234, Copenhagen, Denmark, diluted in 5% normal mouse serum in 1% BSA in PBS at the concentration of 10 μg total protean/mL). After washing in PBS the sections were mounted in 1,4-diazabicyclo2.2.2.octane (DABCO, Sigma, St. Louis, MO) -containing glycerol (50% glycerol in 2×PBS, 0.1% NaN3 and 100 mg/mL DABCO). The sections were examined and photographed under an ultraviolet-microscope equipped with an epi-illuminator and appropriate filters (Leitz, Wetzlar, Germany).

2.9 Double immunocytochemistry

The sections were incubated with rat-anti-mouse IL-10 (IgG2b; Pharmingen, clone JES5-16E3, to 2.0 μg/mL in 1% BSA in PBS; Sigma, St. Louis, MO) for 60 minutes. The sections were washed in PBS and incubated for 60 minutes with the secondary antibody (FITC-conjugated rabbit-anti-rat Ig, Dako, Copenhagen, Denmark, diluted in 5% normal mouse serum in 1% BSA in PBS at the concentration of 10 μg total protein/mL). The sections were washed in PBS and incubated for 60 minutes with the phycoerythrin-conjugated rat-anti-mouse CD11b (IgG2b; Pharmingen, clone M1/70, diluted to 2.0 μg/mL in 1% BSA) for 60 minutes. After washing in PBS the sections were mounted in 1,4-diazabicyclo2.2.2.octane (DABCO, no. D 2522, Sigma, St. Louis, MO)-containing glycerol (50% glycerol in 2×PBS, 0.1% NaN3 and 100 μg/mL DABCO), examined and photographed under an ultraviolet-microscope equipped with an epi-illuminator and appropriate filters (Leitz, Wetzlar, Germany).

3 Results

3.1 IL-6

IL-6 was detected in the testes of postpubertal intact mice, mice treated for 70 days with testosterone or empty implants and cryptorchid and sham-operated mice. IL-6 is localised to the Leydig cells (Figs. 1a and b). Of the 77 mice studied, 15 (19.5%) had IL-6 expressing cells at least in the other testis. There were no differences in the expression of IL-6 between the testosterone and empty implant-treated mice or between the cryptorchid and sham-operated mice.

3.2 IL-10

IL-10+ cells were present in all the studied testes except in two mice treated with testosterone for 17 days, in all three mice vasectomized for 52 days, in one mouse each in the 14, 35 and 52 days sham-operated groups as well as in all the three mice in the varicocele group. Thus, 66 mice out of 77 (85.7%) investigated were positive for IL-10. IL-10 was localised at the interstitial cells (Figures. 1c-h). Two types of IL-10+ cells were present, 1) morphologically macrophage (mφ)-like cells, 2) other interstitial cells, probably Leydig cells. The latter often showed weaker staining intensity than the mφ-like IL-10+ cells. The identity of the IL-10+ morphologically mφ-like cells was investigated using double immunocytochemistry. The IL-10+ mφ-like cells were found in several treatment groups: prepubertal intact mice, postpubertal intact mice (11 weeks old), mice treated for 52 days with testosterone or empty implant, mice treated for 35, 52 and 70 days with an empty implant, mice treated 70 days with a testosterone implant, 35 and 70 days vasectomized and sham operated (vasectomy control) mice, mice treated for 7 days with estrogen, and 14 days sham operated (varicocele control) mice. In 30 mice out of 77 (39.0%) IL-10+ mφ cells were detected in the interstitial tissue of the testis (Table 1). Double staining was made to identify the IL-10+, morphologically mφ-like cells. IL-10 colocalized with the macrophage-specific CD11b in the testes of intact 9-11 weeks old mice (Figure 2). As the normal mouse testis does not contain granulocytes, the IL-10+ interstitial cells were thus most probably macrophages.

3.3 Other cytokines and controls

All other cytokines (IL-2, IL-4 Figures 1k and 1l, IL-12, IFN-γ and TNF-α) were not found in any of the investigated testes (Table 1). The negative control sections incubated with normal serum (diluted 1-100 in 1% BSA in PBS) did not contain any stained cells. Immunocytochemistry of CD106 (Figures 1i and 1j) was used as apositive control. CD106 was expressed strongly by the Leydig cells in all cases.

Figure 1. a) IL-6 in interstitial tissue of a mouse treated with a testosterone implant for 35 days; immunocytochemistry on a frozen section (×1267), b) the samefield as in Figure 1a, a phase contrast (×1267), c) IL-10+ cells (arrows) in interstitial tissue of a mouse treated with an empty implant for 52 days; immunocytochemistry on a frozen section (×1267), d) the same field as in Figure 1c, phase contrast (×1267), e) IL-10+ cells (arrows) in interstitial tissue of amouse treated with an empty implant for 52 days; immunocytochemistry on a frozen section (×633), f) the same field as in Figure 1e, phase contrast (×633), g) IL-10 in the interstitial tissue of a mouse treated with a testosterone implant for 70 days; immunocytochemistry on a frozen section (×1267), h) the same field as in Figure 1g, phase contrast (×1267), i) CD106 in the interstitial tissue of a mouse testis 52 days after vasectomy; immunocytochemistry on a frozen section (×1267),j) the same field as in figure 1i, phase contrast (×1267), k) IL-4 staining of a testis of a mouse treated with an empty implant for 52 days, IL-4 is not present; immunocytochemistry on frozen section (×1267), l) the same field as in Figure1k, phase contrast (×1267).
Figure 2. IL-10 immunocytochemistry on frozen section (a and d) as well as CD11b (b and e), the same field in c as in a and b, the same field in f as in d and e. Figure 1a-c ×1267, Figure 1d-f ×633.
Figure 3. A simplified illustration of immunological microenvironment of testis. If a T cell migrating into testicular interstitial tissue meets its antigen there on MHC-II of testicular macrophages (MΦ), it should go anergic because of lack of necessary co-stimulating factors CD80 and CD86[60]. In addition to lack of necessary co-stimulation, clonal anergy is promoted by secretion of IL-10 by test icular interstitial cells as shown in present study. Furthermore, TGFβ-1 produced by Sertoli cells affects Tcell activation in this site. FasL affects only activated T cells.

Table 1. Presence of IL-10+ Leydig cells, IL-10+ macrophage-like cells, IL-6, IL-2, IL-4, IL-12, TNF-α and IFN-γ in testes of mice after various treatments.

Treatment groups

IL-10+
Leydig-like cells

IL-10+ mΦ
-like cells

IL-6

IL-2

IL-4

IL-12

TNF-α

IFN-γ

Intact mice:

Prepubertal. (10 d)

4/4

2/4

0/4

0/4

0/4

0/4

0/4

0/4

Pubertal. (4 w)

3/3

0/3

0/3

0/3

0/3

0/3

0/3

0/3

Postpub. (9-11 w)

3/3

3/3ad

3/3adg

0/3

0/3

0/3

0/3

0/3

Postpub. (26 w)

4/4

0/4

0/4

0/4

0/4

0/4

0/4

0/4

Testosterone implant:

17 d

1/3

0/3

0/3

0/3

0/3

0/3

0/3

0/3

35 d

3/3

0/3

0/3

0/3

0/3

0/3

0/3

0/3

52 d

3/3

0/3v

0/3

0/3

0/3

0/3

0/3

0/3

70 d

3/3

3/3jmp

0/3

0/3

0/3

0/3

0/3

0/3

Empty implant:

17 d

3/3

0/3

0/3

0/3

0/3

0/3

0/3

0/3

35 d

3/3

1/3

0/3

0/3

0/3

0/3

0/3

0/3

52 d

3/3

3/3

0/3

0/3

0/3

0/3

0/3

0/3

70 d

3/3

3/3j

3/3jmp

0/3

0/3

0/3

0/3

0/3

Vasectomized:

17 d

3/3p

0/3

0/3

0/3

0/3

0/3

0/3

0/3

35 d

3/3p

2/3

0/3

0/3

0/3

0/3

0/3

0/3

52 d

0/3

0/3

0/3

0/3

0/3

0/3

0/3

0/3

70 d

3/3p

3/3jp

0/3

0/3

0/3

0/3

0/3

0/3

Sham operated:

17 d

3/3

0/3

0/3

0/3

0/3

0/3

0/3

0/3

35 d

2/3

1/3

0/3

0/3

0/3

0/3

0/3

0/3

52 d

2/3

0/3

0/3

0/3

0/3

0/3

0/3

0/3

70 d

3/3

3/3jp

0/3jp

0/3

0/3

0/3

0/3

0/3

Varicocele (14 d)